{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T21:14:07Z","timestamp":1781558047868,"version":"3.54.5"},"reference-count":40,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2012,6,26]],"date-time":"2012-06-26T00:00:00Z","timestamp":1340668800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2012,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the performance of an interferon\u2010\u03b3 release assay (IGRA) versus the standard tuberculin skin test (TST) as a screening tool for latent tuberculosis (TB) infection prior to the initiation of anti\u2013tumor necrosis factor therapy in patients with autoimmune inflammatory diseases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This integrated analysis involved screening of patients with rheumatoid arthritis, those with psoriatic arthritis, and those with ankylosing spondylitis from phase III trials of golimumab. The IGRA used to screen for latent TB was the QuantiFERON\u2010TB Gold In\u2010Tube test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In this pooled analysis, 2,282 patients underwent both IGRA and TST screening prior to golimumab treatment. Among these patients, 13.8% had at least one test yielding positive findings for latent TB, including 9.4% with positive results by TST, 7.0% with positive results by IGRA, and 2.6% with positive results on both tests. The rate of indeterminate results for TB on IGRA was 1.8%. Agreement between the TST and IGRA results, measured by the kappa coefficient, was 0.22 (95% confidence interval 0.157\u20130.279;\n                      <jats:italic>P<\/jats:italic>\n                      = 0.021). Among the patients with positive IGRA findings, 36.9% had positive TST findings. Among the patients with positive TST findings, 27.4% had positive IGRA findings. Overall, 781 (34.2%) of the 2,282 patients had previously received the bacillus Calmette\u2010Gu\u00e9rin (BCG) vaccine; among this vaccinated group, the rate of positivity for latent TB by TST was 15.2% (119 of 781), compared to a rate of positivity of 9.1% (71 of 781) by IGRA (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.0002). Among patients who had not received the BCG vaccine, the rate of positivity by TST was 5.0% (62 of 1,248) and the rate of positivity by IGRA was 5.8% (72 of 1,248) (\n                      <jats:italic>P<\/jats:italic>\n                      = 0.3745). When the IGRA was repeated in patients whose results were initially indeterminate, the rate of indeterminate IGRA findings for latent TB was much lower than has been previously reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the absence of a true gold standard test for latent TB infection, results of this comparison of IGRA and TST in a large cohort of patients with rheumatic diseases suggest that the IGRA provides greater specificity and possibly greater sensitivity than the TST.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/art.34382","type":"journal-article","created":{"date-parts":[[2012,1,11]],"date-time":"2012-01-11T14:32:36Z","timestamp":1326292356000},"page":"2068-2077","source":"Crossref","is-referenced-by-count":79,"title":["Interferon\u2010\u03b3 release assay versus tuberculin skin test prior to treatment with golimumab, a human anti\u2013tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis"],"prefix":"10.1002","volume":"64","author":[{"given":"Elizabeth C.","family":"Hsia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Schluger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Cush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Chaisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric L.","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Beutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mittie K.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahboob U.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,6,26]]},"reference":[{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.123885"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2048"},{"key":"e_1_2_8_4_2","first-page":"776","article-title":"Comparison of an interferon\u2010\u03b3 assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB\u2010endemic population","volume":"35","author":"Ponce de Leon D","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.069799"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07829.x"},{"key":"e_1_2_8_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.06070.x"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.20009"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(03)00545-0"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh567"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.11137"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090268"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem351"},{"key":"e_1_2_8_15_2","first-page":"770","article-title":"Comparison of an in vitro tuberculosis interferon\u2010\u03b3 assay with delayed\u2010type hypersensitivity testing for detection of latent Mycobacterium tuberculosis: a pilot study in rheumatoid arthritis","volume":"35","author":"Greenberg JD","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_8_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.070789"},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00040007"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200502-196OC"},{"key":"e_1_2_8_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-1377-8"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24638"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.099010"},{"key":"e_1_2_8_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24403"},{"key":"e_1_2_8_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.23969"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60506-7"},{"key":"e_1_2_8_25_2","volume-title":"QuantiFERON\u2010TB Gold clinicians guide and QuantiFERON\u2010TB Gold In\u2010Tube Method","year":"2010"},{"key":"e_1_2_8_26_2","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection","volume":"49","author":"Centers for Disease Control and Prevention \/ American Thoracic Society","year":"2000","journal-title":"MMWR"},{"key":"e_1_2_8_27_2","first-page":"1","article-title":"Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection\u2014United States, 2010","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-2575"},{"key":"e_1_2_8_29_2","first-page":"1177","article-title":"Interferon\u2010gamma assays for the diagnosis of tuberculosis infection before using tumour necrosis factor\u2010alpha blockers","volume":"11","author":"Cobanoglu N","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-008-0519-1"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-9-207"},{"key":"e_1_2_8_32_2","first-page":"1190","article-title":"Utility of QuantiFERON\u2010TB Gold in\u2010tube testing for latent TB infection in HIV\u2010infected individuals","volume":"11","author":"Jones S","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200608-1088OC"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-149-3-200808050-00241"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2008.02050.x"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-7-56"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)68579-6"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.1086\/597351"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tube.2007.11.009"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200711-1613OC"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21734"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.34382","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.34382","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T17:27:55Z","timestamp":1696958875000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.34382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,26]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.1002\/art.34382"],"URL":"https:\/\/doi.org\/10.1002\/art.34382","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717597853.792952901","asserted-by":"object"}]},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,26]]}}}